Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Komada

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Therapeutic Drug Monitoring|January 8, 1998
Cross-reactivity of TDX and OPUS immunoassay systems for serum digoxin determinationM Okazaki, Y Tanigawara, T Kita, et al.
Blood|April 1, 1990
A role for calmodulin in the growth of human hematopoietic progenitor cellsN Katayama, M Nishikawa, F Komada, et al.
Pharmaceutical Research|September 1, 1989
Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humansR Hori, F Komada, S Iwakawa, et al.
Journal of Pharmaceutical Sciences|June 1, 1994
Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lungF Komada, S Iwakawa, N Yamamoto, et al.
Pigment Cell Research|February 1, 1992
Tissue distribution of para-boronophenylalanine administered orally as a cyclodextrin inclusion complex to melanoma-bearing hamstersH Hatanaka, F Komada, M Shiono, et al.
Biological & Pharmaceutical Bulletin|May 1, 1996
Effect of clarithromycin on the bioavailability of cyclosporin in ratsM Ohba, N Ohnishi, F Komada, et al.
Biological & Pharmaceutical Bulletin|September 10, 1999
Effects of secretable SOD delivered by genetically modified cells on xanthine/xanthine oxidase and paraquat-induced cytotoxicity in vitroF Komada, K Nishiguchi, Y Tanigawara, et al.
Biological & Pharmaceutical Bulletin|January 1, 1993
Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open woundsY Kiyohara, F Komada, S Iwakawa, et al.
Cancer Research|February 1, 1990
Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diesterM Nishikawa, F Komada, Y Uemura, et al.
Japanese Journal of Cancer Research : Gann|April 13, 2000
The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoproteinK Takara, Y Tanigawara, F Komada, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|January 8, 1998
Cross-reactivity of TDX and OPUS immunoassay systems for serum digoxin determinationM Okazaki, Y Tanigawara, T Kita, et al.
Blood|April 1, 1990
A role for calmodulin in the growth of human hematopoietic progenitor cellsN Katayama, M Nishikawa, F Komada, et al.
Pharmaceutical Research|September 1, 1989
Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humansR Hori, F Komada, S Iwakawa, et al.
Journal of Pharmaceutical Sciences|June 1, 1994
Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lungF Komada, S Iwakawa, N Yamamoto, et al.
Pigment Cell Research|February 1, 1992
Tissue distribution of para-boronophenylalanine administered orally as a cyclodextrin inclusion complex to melanoma-bearing hamstersH Hatanaka, F Komada, M Shiono, et al.
Biological & Pharmaceutical Bulletin|May 1, 1996
Effect of clarithromycin on the bioavailability of cyclosporin in ratsM Ohba, N Ohnishi, F Komada, et al.
Biological & Pharmaceutical Bulletin|September 10, 1999
Effects of secretable SOD delivered by genetically modified cells on xanthine/xanthine oxidase and paraquat-induced cytotoxicity in vitroF Komada, K Nishiguchi, Y Tanigawara, et al.
Biological & Pharmaceutical Bulletin|January 1, 1993
Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open woundsY Kiyohara, F Komada, S Iwakawa, et al.
Cancer Research|February 1, 1990
Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diesterM Nishikawa, F Komada, Y Uemura, et al.
Japanese Journal of Cancer Research : Gann|April 13, 2000
The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoproteinK Takara, Y Tanigawara, F Komada, et al.
Pageof 6